ES2053907T3 - Pomada topica. - Google Patents

Pomada topica.

Info

Publication number
ES2053907T3
ES2053907T3 ES89119890T ES89119890T ES2053907T3 ES 2053907 T3 ES2053907 T3 ES 2053907T3 ES 89119890 T ES89119890 T ES 89119890T ES 89119890 T ES89119890 T ES 89119890T ES 2053907 T3 ES2053907 T3 ES 2053907T3
Authority
ES
Spain
Prior art keywords
pct
topical
pomada
sec
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89119890T
Other languages
English (en)
Spanish (es)
Inventor
Gabriele Flender
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCHURMANN GABRIELE
Original Assignee
SCHURMANN GABRIELE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCHURMANN GABRIELE filed Critical SCHURMANN GABRIELE
Application granted granted Critical
Publication of ES2053907T3 publication Critical patent/ES2053907T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ES89119890T 1988-10-31 1989-10-26 Pomada topica. Expired - Lifetime ES2053907T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3836971A DE3836971C1 (pt) 1988-10-31 1988-10-31

Publications (1)

Publication Number Publication Date
ES2053907T3 true ES2053907T3 (es) 1994-08-01

Family

ID=6366210

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89119890T Expired - Lifetime ES2053907T3 (es) 1988-10-31 1989-10-26 Pomada topica.

Country Status (11)

Country Link
US (1) US5179086A (pt)
EP (2) EP0367103B1 (pt)
JP (1) JPH0647544B2 (pt)
AT (1) ATE84216T1 (pt)
CA (1) CA2001797A1 (pt)
DE (2) DE3836971C1 (pt)
DK (1) DK7191A (pt)
ES (1) ES2053907T3 (pt)
GR (1) GR3007370T3 (pt)
PT (1) PT92148B (pt)
WO (1) WO1990004967A2 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705030A1 (fr) * 1993-05-11 1994-11-18 Biodev Utilisation de composés stéroliques pour la fabrication d'un médicament anti-inflammatoire.
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US5444092A (en) * 1994-07-20 1995-08-22 Collins; Jerry Method and composition for treating psoriasis
GB9814527D0 (en) * 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
EP1135410B1 (en) * 1998-11-13 2008-12-31 Cyclacel Limited Antennapedia homeodomain helix 3 derived translocation vectors
ATE361082T1 (de) 1999-02-01 2007-05-15 Dermal Res Lab Inc Pharmazeutische zusammensetzung aus komplexen kohlenhydraten deren anwendung
US7879824B2 (en) * 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
TNSN02063A1 (en) * 2001-07-07 2005-12-23 Egyptian Natural Oil Co Natoil The medical effect of jojoba oil
US7048914B2 (en) * 2002-12-12 2006-05-23 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
US20050002884A1 (en) * 2003-07-02 2005-01-06 Marsella Jefferson Hair treatment compositions
US7374754B2 (en) * 2003-09-02 2008-05-20 Essential Skincare, Llc Use of placental alkaline phosphatase to promote skin cell proliferation
US8455016B2 (en) * 2004-03-12 2013-06-04 Melbj Holdings, Llc Treatment for meibomian gland dysfunction or obstruction
US7695714B2 (en) * 2005-12-28 2010-04-13 Zoltan Laboratories Llc Use of alkaline phosphatase to maintain healthy tissue mass in mammals
EP2368627A4 (en) * 2008-12-24 2015-01-14 Biomedcore Inc METHOD FOR MANUFACTURING LIPOSOME AND METHOD FOR DISSOLVING CHOLESTEROL
US20130053358A1 (en) 2010-04-28 2013-02-28 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable donepezil-containing preparation
US20130053357A1 (en) 2010-04-28 2013-02-28 Hisamitsu Pharmaceutical Co., Inc. Skin irritation suppressant and transdermal preparation
JP5462421B2 (ja) 2011-10-26 2014-04-02 久光製薬株式会社 オキシブチニン含有経皮吸収製剤
US9717741B2 (en) 2012-10-11 2017-08-01 Anaplasi Pharmaceuticals Llc Method and compositions for treating psoriasis
US9987361B1 (en) 2014-12-29 2018-06-05 Noven Pharmaceuticals, Inc. Compositions and method for sustained drug delivery by active transdermal technology
CN113056281B (zh) * 2018-11-01 2023-05-26 耶迪特普大学 用于治疗牛皮癣的药物及其生产方法
GB201918752D0 (en) * 2019-12-18 2020-01-29 Ucl Business Plc New therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE523144C (de) * 1927-09-11 1931-04-20 Friedrich Passek Verfahren zur Herstellung wasserreicher Cholesterinloesungen
DE638839C (de) * 1935-01-15 1936-11-24 Chem Fab Promonta G M B H Verfahren zur Herstellung waessrig-alkoholischer Cholesterinloesungen
FR928337A (fr) * 1946-05-20 1947-11-25 Procédé d'obtention de solutions stables de cholestérine, en vue de la préparation de produits cosmétiques et de beauté
FR2485921A1 (fr) * 1980-07-01 1982-01-08 Oreal Composition cosmetique a base d'une dispersion aqueuse de spherules lipidiques
IT8221553A0 (it) * 1982-05-28 1982-05-28 Gruppo Scient Revici Pacelli Composizioni farmaceutiche adattivita' antineoplastica.
DE3225849A1 (de) * 1982-07-07 1984-01-19 Schering Ag Kortikoidhaltige zubereitung zur topischen applikation
FR2568142B1 (pt) * 1984-07-26 1989-11-17 Oreal
US4743597A (en) * 1986-01-27 1988-05-10 Javitt Norman B Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases
FR2597346B1 (fr) * 1986-04-22 1989-08-18 Oreal Procede pour faciliter la formation de niosomes en dispersion dans une phase aqueuse et pour ameliorer leur stabilite et leur taux d'encapsulation, et dispersions correspondantes.

Also Published As

Publication number Publication date
JPH04501415A (ja) 1992-03-12
EP0367103A1 (de) 1990-05-09
EP0440715A1 (de) 1991-08-14
DE58903222D1 (de) 1993-02-18
ATE84216T1 (de) 1993-01-15
US5179086A (en) 1993-01-12
PT92148B (pt) 1995-06-30
WO1990004967A2 (de) 1990-05-17
PT92148A (pt) 1990-05-31
JPH0647544B2 (ja) 1994-06-22
DE3836971C1 (pt) 1990-05-17
GR3007370T3 (pt) 1993-07-30
CA2001797A1 (en) 1990-04-30
DK7191A (da) 1991-06-04
WO1990004967A3 (de) 1990-06-28
DK7191D0 (da) 1991-01-15
EP0367103B1 (de) 1993-01-07

Similar Documents

Publication Publication Date Title
ES2053907T3 (es) Pomada topica.
PT912176E (pt) Utilizacao de amidas do acido piridil-alcanoico piridil-alcenoico e/ou piridil-alcinico para o tratamento de tumores ou para imunossupressao
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
TR200200068T2 (tr) Nematisital triflüorobütenler
DE59209810D1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
NO954320D0 (no) Lyosfærer omfattende gonadotropin
DE69428334T2 (de) Wässrige Lösungen enthaltend Inklusionskomplexe aus Benzothiophenderivaten und Cyclodextrinen
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
DK71387A (da) Terapeutisk middel til behandling af psoriasis
ATE179594T1 (de) Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
ATE215084T1 (de) Imidazopyridin-azolidinone
DK0841937T3 (da) Anvendelse af betaglycan til reduktion af ardannelse
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung
ATE221068T1 (de) Anellierte beta-carboline
ITPN910075A1 (it) Procedimento di costruzione di telai in fibra di carbonio.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 367103

Country of ref document: ES